0S9E.L
Extendicare Inc. [0S9E.L] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
0S9E.L Stock Summary
In the News
0S9E.L Financial details
Company Rating
Strong Buy
Market Cap
607.55M
Income
33.98M
Revenue
1.3B
Book val./share
1.04
Cash/share
0.9
Dividend
0.16
Dividend %
2.21%
Employees
23.5K
Optionable
No
Shortable
Yes
Earnings
02 May 2024
P/E
34.85
Forward P/E
-
PEG
-0.4
P/S
0.01
P/B
6.44
P/C
8.03
P/FCF
-0.07
Quick Ratio
0.77
Current Ratio
0.9
Debt / Equity
3.38
LT Debt / Equity
3.16
-
-
EPS (TTM)
0.4
EPS next Y
-
EPS next Q
-
EPS this Y
-860.46%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
4.56%
Revenue last 5Y
2.89%
Revenue Q/Q
8.57%
EPS Q/Q
-28.57%
-
-
-
-
SMA20
-1.43%
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
3%
ROE
18%
ROC
-0.06%
Gross Margin
5%
Oper. Margin
-2%
Profit Margin
1%
Payout
231%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.0-7.36
52W High
-
52W Low
-
RSI
62.57
Rel Volume
0.17
Avg Volume
12
Volume
2
Perf Week
4.48%
Perf Month
0.42%
Perf Quarter
-
Perf Half Y
0%
-
-
-
-
Beta
1.221
-
-
Volatility
0.19%, 0.14%
Prev Close
1.12%
Price
7.23
Change
1.12%
0S9E.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 12.7 | 12.29 | 12.97 | 13.72 | 15.36 | |
| Net income per share | 0.32 | 0.6 | 0.13 | -0.05 | 0.4 | |
| Operating cash flow per share | 0.49 | 1.31 | 0.64 | 1.1 | 0.28 | |
| Free cash flow per share | 0.12 | 0.94 | -0.08 | -0.04 | -1.24 | |
| Cash per share | 1.09 | 2.03 | 1.2 | 1.91 | 0.89 | |
| Book value per share | 1.29 | 1.43 | 1.13 | 1.13 | 1.03 | |
| Tangible book value per share | 0.29 | 0.45 | 0.1 | 0.04 | 0.5 | |
| Share holders equity per share | 1.29 | 1.43 | 1.13 | 1.13 | 1.03 | |
| Interest debt per share | 6.56 | 5.91 | 5.61 | 4.02 | 3.75 | |
| Market cap | 668.61M | 557.71M | 651.53M | 580.34M | 606.8M | |
| Enterprise value | 1.13B | 939.84M | 1.08B | 794.33M | 865.4M | |
| P/E ratio | 23.35 | 10.29 | 56.63 | -123.92 | 17.86 | |
| Price to sales ratio | 0.59 | 0.51 | 0.56 | 0.48 | 0.46 | |
| POCF ratio | 15.35 | 4.75 | 11.28 | 5.9 | 25.21 | |
| PFCF ratio | 64.41 | 6.61 | -87.56 | -176.02 | -5.76 | |
| P/B Ratio | 5.79 | 4.35 | 6.39 | 5.76 | 6.9 | |
| PTB ratio | 5.79 | 4.35 | 6.39 | 5.76 | 6.9 | |
| EV to sales | 1 | 0.85 | 0.93 | 0.65 | 0.66 | |
| Enterprise value over EBITDA | 12.22 | 7.12 | 17.11 | 13.83 | 9.09 | |
| EV to operating cash flow | 25.89 | 8 | 18.72 | 8.08 | 35.96 | |
| EV to free cash flow | 108.67 | 11.14 | -145.24 | -240.92 | -8.21 | |
| Earnings yield | 0.04 | 0.1 | 0.02 | -0.01 | 0.06 | |
| Free cash flow yield | 0.02 | 0.15 | -0.01 | -0.01 | -0.17 | |
| Debt to equity | 4.82 | 3.92 | 4.73 | 3.34 | 3.38 | |
| Debt to assets | 0.63 | 0.52 | 0.54 | 0.43 | 0.44 | |
| Net debt to EBITDA | 4.98 | 2.89 | 6.79 | 3.72 | 2.72 | |
| Current ratio | 0.67 | 1.06 | 0.8 | 0.94 | 0.83 | |
| Interest coverage | 1.83 | 3.32 | 1.43 | 1.19 | 2.95 | |
| Income quality | 2.94 | 2.77 | 7.69 | -21.8 | 0.71 | |
| Dividend Yield | 0.06 | 0.07 | 0.07 | 0.07 | 0.07 | |
| Payout ratio | 1.3 | 0.76 | 3.74 | -9.09 | 1.19 | |
| Sales general and administrative to revenue | 0.04 | 0.04 | 0.04 | 0.04 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.1 | 0.09 | 0.1 | 0.12 | 0.07 | |
| Capex to operating cash flow | -0.76 | -0.28 | -1.13 | -1.03 | -5.38 | |
| Capex to revenue | -0.03 | -0.03 | -0.06 | -0.08 | -0.1 | |
| Capex to depreciation | -0.83 | -0.87 | -2.1 | -3.21 | -3.97 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | -0.08 | |
| Graham number | 3.06 | 4.4 | 1.8 | 1.16 | 3.05 | |
| ROIC | 0.05 | 0.1 | 0.03 | 0.05 | 0.11 | |
| Return on tangible assets | 0.04 | 0.06 | 0.01 | -0.01 | 0.05 | |
| Graham Net | -7.03 | -6.65 | -6.98 | -5.2 | -5.18 | |
| Working capital | -91.97M | 16.56M | -56.99M | -16.95M | -39.25M | |
| Tangible asset value | 25.54M | 40.01M | 9.44M | 3.64M | 42.07M | |
| Net current asset value | -589.49M | -538.86M | -573.48M | -422.84M | -397.67M | |
| Invested capital | 4.82 | 3.92 | 4.73 | 3.34 | 3.38 | |
| Average receivables | 53.12M | 69.87M | 78.46M | 73.81M | 77.55M | |
| Average payables | 133.97M | 162M | 190.03M | 221.57M | 226.7M | |
| Average inventory | 0.5 | 0 | 0.5 | 0.5 | 0 | |
| Days sales outstanding | 21.39 | 24.27 | 26.13 | 19.14 | 25.46 | |
| Days payables outstanding | 48.13 | 71.08 | 66.14 | 79.76 | 62.53 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 17.06 | 15.04 | 13.97 | 19.07 | 14.34 | |
| Payables turnover | 7.58 | 5.13 | 5.52 | 4.58 | 5.84 | |
| Inventory turnover | 0 | 0 | 1.07B | 0 | 0 | |
| ROE | 0.25 | 0.42 | 0.11 | -0.05 | 0.39 | |
| Capex per share | -0.37 | -0.37 | -0.72 | -1.14 | -1.52 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 3.58 | 3.8 | 3.61 | 3.79 | 4.15 | |
| Net income per share | -0.09 | 0.14 | 0.02 | 0.14 | 0.1 | |
| Operating cash flow per share | 0.35 | -0.35 | 0.32 | 0.08 | 0.24 | |
| Free cash flow per share | 0.06 | -0.74 | -0.05 | -0.43 | 0 | |
| Cash per share | 1.96 | 1.27 | 1.08 | 1.14 | 0.9 | |
| Book value per share | 1.16 | 1.19 | 1.07 | 1.12 | 1.04 | |
| Tangible book value per share | 0.04 | 0.02 | -0.13 | -0.34 | 0.5 | |
| Share holders equity per share | 1.16 | 1.19 | 1.07 | 1.12 | 1.04 | |
| Interest debt per share | 3.94 | 3.99 | 4.07 | 3.81 | 3.59 | |
| Market cap | 565.14M | 557.05M | 618.64M | 548.31M | 601.88M | |
| Enterprise value | 779.13M | 845.69M | 926.35M | 790.73M | 860.48M | |
| P/E ratio | -17.64 | 12.03 | 79.27 | 11.59 | 17.46 | |
| Price to sales ratio | 1.82 | 1.72 | 2.01 | 1.7 | 1.72 | |
| POCF ratio | 18.82 | -18.48 | 22.78 | 76.66 | 30.25 | |
| PFCF ratio | 116.24 | -8.76 | -133.36 | -14.91 | -1.85K | |
| P/B Ratio | 5.61 | 5.49 | 6.77 | 5.73 | 6.85 | |
| PTB ratio | 5.61 | 5.49 | 6.77 | 5.73 | 6.85 | |
| EV to sales | 2.51 | 2.6 | 3.01 | 2.45 | 2.46 | |
| Enterprise value over EBITDA | 85.06 | 27.3 | 62.69 | 38.07 | 30.02 | |
| EV to operating cash flow | 25.95 | -28.06 | 34.11 | 110.56 | 43.25 | |
| EV to free cash flow | 160.25 | -13.3 | -199.69 | -21.5 | -2.64K | |
| Earnings yield | -0.01 | 0.02 | 0 | 0.02 | 0.01 | |
| Free cash flow yield | 0.01 | -0.11 | -0.01 | -0.07 | 0 | |
| Debt to equity | 3.34 | 3.31 | 3.73 | 3.33 | 3.38 | |
| Debt to assets | 0.43 | 0.45 | 0.45 | 0.46 | 0.44 | |
| Net debt to EBITDA | 23.36 | 9.32 | 20.83 | 11.67 | 9.02 | |
| Current ratio | 0.94 | 0.91 | 0.78 | 0.9 | 0.83 | |
| Interest coverage | 0.26 | 4.34 | 1.4 | 2.23 | 4.01 | |
| Income quality | -3.9 | -2.6 | 13.92 | 0.6 | 2.31 | |
| Dividend Yield | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Payout ratio | -1.3 | 0.88 | 5.2 | 0.85 | 1.16 | |
| Sales general and administrative to revenue | 0.04 | 0.04 | 0.04 | 0.04 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.12 | 0.13 | 0.13 | 0.18 | 0.07 | |
| Capex to operating cash flow | -0.84 | 1.11 | -1.17 | -6.14 | -1.02 | |
| Capex to revenue | -0.08 | -0.1 | -0.1 | -0.14 | -0.06 | |
| Capex to depreciation | -3.26 | -4.33 | -4.21 | -4.67 | -2.37 | |
| Stock based compensation to revenue | 0.01 | 0 | 0 | 0 | -0.07 | |
| Graham number | 1.55 | 1.9 | 0.74 | 1.88 | 1.55 | |
| ROIC | 0 | 0.03 | 0.01 | 0.02 | 0.03 | |
| Return on tangible assets | -0.01 | 0.02 | 0 | 0.02 | 0.01 | |
| Graham Net | -5.34 | -5.62 | -6.09 | -5.11 | -5.23 | |
| Working capital | -16.95M | -21.09M | -54.82M | -23.69M | -39.25M | |
| Tangible asset value | 3.64M | 1.46M | -11.33M | -29.25M | 42.07M | |
| Net current asset value | -422.84M | -439.07M | -475.43M | -386.46M | -397.67M | |
| Invested capital | 3.34 | 3.31 | 3.73 | 3.33 | 3.38 | |
| Average receivables | 68.24M | 69.44M | 78.68M | 81.75M | 85.98M | |
| Average payables | 235.87M | 227.39M | 218.4M | 219.6M | 205.15M | |
| Average inventory | 0 | 0 | 0 | 0.5 | 0.5 | |
| Days sales outstanding | 18.58 | 20.73 | 24.16 | 22.59 | 23.39 | |
| Days payables outstanding | 75.94 | 63.98 | 72.9 | 62.8 | 57.9 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 4.84 | 4.34 | 3.73 | 3.98 | 3.85 | |
| Payables turnover | 1.19 | 1.41 | 1.23 | 1.43 | 1.55 | |
| Inventory turnover | 0 | 0 | 0 | 296.72M | 0 | |
| ROE | -0.08 | 0.11 | 0.02 | 0.12 | 0.1 | |
| Capex per share | -0.29 | -0.39 | -0.37 | -0.52 | -0.24 |
0S9E.L Frequently Asked Questions
What is Extendicare Inc. stock symbol ?
Extendicare Inc. is a CA stock , located in Markham of On and trading under the symbol 0S9E.L
What is Extendicare Inc. stock quote today ?
Extendicare Inc. stock price is $7.23 today.
Is Extendicare Inc. stock public?
Yes, Extendicare Inc. is a publicly traded company.
Company Profile
- Volume Average 12
- Market Capitalization 607.55M
- Employee 23.5K
- CEO Mr. David E. Bacon
- Headquarters Markham,ON,CA
- IPO Date 2022-11-11
-
Website
https://www.extendicare.com 
Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; retirement living services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as contract and consulting services to third parties. It operates a network of 119 LTC homes and retirement communities, as well as home health care operations under the Extendicare, Esprit Lifestyle Communities, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. Extendicare Inc. was founded in 1968 and is based in Markham, Canada.
